GR890100540A - Hybrid particle immunogens - Google Patents

Hybrid particle immunogens

Info

Publication number
GR890100540A
GR890100540A GR89100540A GR890100540A GR890100540A GR 890100540 A GR890100540 A GR 890100540A GR 89100540 A GR89100540 A GR 89100540A GR 890100540 A GR890100540 A GR 890100540A GR 890100540 A GR890100540 A GR 890100540A
Authority
GR
Greece
Prior art keywords
hybrid particle
particle immunogens
immunogens
hybrid
particle
Prior art date
Application number
GR89100540A
Other languages
Greek (el)
Other versions
GR1000321B (en
Inventor
Scott C Chappel
Noreen P Nugent
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of GR890100540A publication Critical patent/GR890100540A/en
Publication of GR1000321B publication Critical patent/GR1000321B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR890100540A 1988-08-30 1989-08-30 Hybrid particle immunogens GR1000321B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24655888A 1988-08-30 1988-08-30

Publications (2)

Publication Number Publication Date
GR890100540A true GR890100540A (en) 1990-08-22
GR1000321B GR1000321B (en) 1992-06-25

Family

ID=22931196

Family Applications (1)

Application Number Title Priority Date Filing Date
GR890100540A GR1000321B (en) 1988-08-30 1989-08-30 Hybrid particle immunogens

Country Status (9)

Country Link
EP (1) EP0396653A1 (en)
JP (1) JPH03502584A (en)
AU (1) AU629237B2 (en)
DK (1) DK106590D0 (en)
FI (1) FI902151A0 (en)
GR (1) GR1000321B (en)
IL (1) IL91462A0 (en)
WO (1) WO1990002187A1 (en)
ZA (1) ZA896628B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0448513A3 (en) * 1990-03-21 1991-12-27 Japat Ltd Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof
GB9101550D0 (en) * 1991-01-24 1991-03-06 Mastico Robert A Antigen-presenting chimaeric protein
JPH05339295A (en) * 1991-12-05 1993-12-21 Agency Of Ind Science & Technol Preparation of antibody
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
DK1035133T3 (en) * 1999-02-17 2005-05-02 Pfizer Prod Inc Fusion proteins comprising carriers that can induce a dual immune response
AU2001259452A1 (en) 2000-05-05 2001-11-20 Aphton Corporation Chimeric peptide immunogens their preparation and use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0175261A2 (en) * 1984-09-12 1986-03-26 Chiron Corporation Hybrid particle immunogens
WO1986006635A1 (en) * 1985-05-15 1986-11-20 Biotechnology Australia Pty. Ltd. Oral vaccines
WO1986007383A1 (en) * 1985-06-04 1986-12-18 Biotechnology Research Partners, Ltd. Autoantigen vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963691A (en) * 1974-10-07 1976-06-15 Merck & Co., Inc. Synthetic antigens of luteinizing hormone releasing hormone
GB8314362D0 (en) * 1983-05-24 1983-06-29 Celltech Ltd Polypeptide and protein products
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0175261A2 (en) * 1984-09-12 1986-03-26 Chiron Corporation Hybrid particle immunogens
WO1986006635A1 (en) * 1985-05-15 1986-11-20 Biotechnology Australia Pty. Ltd. Oral vaccines
WO1986007383A1 (en) * 1985-06-04 1986-12-18 Biotechnology Research Partners, Ltd. Autoantigen vaccines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CLAIMS SEARCHED: ALL *

Also Published As

Publication number Publication date
IL91462A0 (en) 1990-04-29
AU629237B2 (en) 1992-10-01
AU4076189A (en) 1990-03-23
GR1000321B (en) 1992-06-25
EP0396653A1 (en) 1990-11-14
DK106590A (en) 1990-04-30
DK106590D0 (en) 1990-04-30
JPH03502584A (en) 1991-06-13
ZA896628B (en) 1991-04-24
FI902151A0 (en) 1990-04-27
WO1990002187A1 (en) 1990-03-08

Similar Documents

Publication Publication Date Title
EP0312225A3 (en) Particle accelerator
EP0328113A3 (en) Member for charging
IL85786A (en) Hybrid surface coil
GB2210183B (en) Energy-transfer arrangement
GB2230547B (en) Bridge-laying vehicle
DK172090A (en) Trolley
GR890100540A (en) Hybrid particle immunogens
GB2228007A (en) Hybrid proteins
GB8813948D0 (en) Road-sweeping vehicle
GB8810631D0 (en) Trolley
GB2224982B (en) Vehicle
GB2221181B (en) Bag manufacture
GB2225760B (en) Wind-propelled vehicle
GB8812056D0 (en) Vehicle
GB8908376D0 (en) Vehicle
GB8819641D0 (en) Improved vehicle
AU11P (en) ULTRAVIOLET Lechenaultia hybrid
GB8820396D0 (en) Vehicle
GB9208218D0 (en) Hybrid particles
GB2254424B (en) Hybrid envelope genes
GB8822213D0 (en) Hybrid molecules
GB8812060D0 (en) Electric vehicle
GB8813113D0 (en) Hybrid proteins
GB8825330D0 (en) Hybrid proteins
BG47059A1 (en) Means for implementing